94 related articles for article (PubMed ID: 7865772)
1. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide induces anxiolytic effects in rat.
Skutella T; Criswell H; Moy S; Probst JC; Breese GR; Jirikowski GF; Holsboer F
Neuroreport; 1994 Oct; 5(16):2181-5. PubMed ID: 7865772
[TBL] [Abstract][Full Text] [Related]
2. Corticotropin-releasing hormone (CRH) antisense oligodeoxynucleotide treatment attenuates social defeat-induced anxiety in rats.
Skutella T; Montkowski A; Stöhr T; Probst JC; Landgraf R; Holsboer F; Jirikowski GF
Cell Mol Neurobiol; 1994 Oct; 14(5):579-88. PubMed ID: 7621515
[TBL] [Abstract][Full Text] [Related]
3. Antisense oligodeoxynucleotides for in vivo targeting of corticotropin-releasing hormone mRNA: comparison of phosphorothioate and 3'-inverted probe performance.
Skutella T; Stöhr T; Probst JC; Ramalho-Ortigao FJ; Holsboer F; Jirikowski GF
Horm Metab Res; 1994 Oct; 26(10):460-4. PubMed ID: 7851868
[TBL] [Abstract][Full Text] [Related]
4. An antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA inhibits rat splenocyte proliferation in vitro.
Jessop DS; Harbuz MS; Snelson CL; Dayan CM; Lightman SL
J Neuroimmunol; 1997 May; 75(1-2):135-40. PubMed ID: 9143246
[TBL] [Abstract][Full Text] [Related]
5. A corticotropin-releasing hormone antisense oligodeoxynucleotide reduces spontaneous waking in the rat.
Chang FC; Opp MR
Regul Pept; 2004 Jan; 117(1):43-52. PubMed ID: 14687700
[TBL] [Abstract][Full Text] [Related]
6. Chronic infusion of a CRH1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats.
Liebsch G; Landgraf R; Gerstberger R; Probst JC; Wotjak CT; Engelmann M; Holsboer F; Montkowski A
Regul Pept; 1995 Oct; 59(2):229-39. PubMed ID: 8584759
[TBL] [Abstract][Full Text] [Related]
7. Effects of continuous infusion of interleukin 1 beta on corticotropin-releasing hormone (CRH), CRH receptors, proopiomelanocortin gene expression and secretion of corticotropin, beta-endorphin and corticosterone.
Parsadaniantz SM; Batsché E; Gegout-Pottie P; Terlain B; Gillet P; Netter P; Kerdelhué B
Neuroendocrinology; 1997 Jan; 65(1):53-63. PubMed ID: 9032774
[TBL] [Abstract][Full Text] [Related]
8. Desensitization of the hypothalamic-pituitary-adrenal axis following prolonged administration of corticotropin-releasing hormone or vasopressin.
Tizabi Y; Aguilera G
Neuroendocrinology; 1992 Nov; 56(5):611-8. PubMed ID: 1336816
[TBL] [Abstract][Full Text] [Related]
9. Differential behavioural effects of chronic infusion of CRH 1 and CRH 2 receptor antisense oligonucleotides into the rat brain.
Liebsch G; Landgraf R; Engelmann M; Lörscher P; Holsboer F
J Psychiatr Res; 1999; 33(2):153-63. PubMed ID: 10221747
[TBL] [Abstract][Full Text] [Related]
10. Rat strains that differ in corticotropin-releasing hormone production exhibit different sleep-wake responses to interleukin 1.
Opp MR; Imeri L
Neuroendocrinology; 2001 Apr; 73(4):272-84. PubMed ID: 11340341
[TBL] [Abstract][Full Text] [Related]
11. Antisense oligonucleotides in neuroendocrinology: enthusiasm and frustration.
Neumann I
Neurochem Int; 1997 Sep; 31(3):363-78. PubMed ID: 9246679
[TBL] [Abstract][Full Text] [Related]
12. Effects of corticosterone on CRH mRNA and content in the bed nucleus of the stria terminalis; comparison with the effects in the central nucleus of the amygdala and the paraventricular nucleus of the hypothalamus.
Makino S; Gold PW; Schulkin J
Brain Res; 1994 Sep; 657(1-2):141-9. PubMed ID: 7820612
[TBL] [Abstract][Full Text] [Related]
13. Olfactory bulbectomy increases vasopressin, but not corticotropin-releasing hormone, content in the external layer of the median eminence of male rats.
Marcilhac A; Anglade G; Hery F; Siaud P
Neurosci Lett; 1999 Mar; 262(2):89-92. PubMed ID: 10203238
[TBL] [Abstract][Full Text] [Related]
14. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
Herman JP; Wiegand SJ; Watson SJ
Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
[TBL] [Abstract][Full Text] [Related]
15. The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus.
Patchev VK; Shoaib M; Holsboer F; Almeida OF
Neuroscience; 1994 Sep; 62(1):265-71. PubMed ID: 7816204
[TBL] [Abstract][Full Text] [Related]
16. Antisense oligonucleotides to corticotropin-releasing factor impair memory retention and increase exploration in rats.
Wu HC; Chen KY; Lee WY; Lee EH
Neuroscience; 1997 May; 78(1):147-53. PubMed ID: 9135096
[TBL] [Abstract][Full Text] [Related]
17. Corticotropin-releasing hormone is produced by rat corticotropes and modulates ACTH secretion in a paracrine/autocrine fashion.
Pecori Giraldi F; Cavagnini F
J Clin Invest; 1998 Jun; 101(11):2478-84. PubMed ID: 9616219
[TBL] [Abstract][Full Text] [Related]
18. Role of glucocorticoids in the modulation of corticotropin-releasing hormone mRNA level by the endogenous benzodiazepine receptor ligand octadecaneuropeptide in rat brain.
Givalois L; Li S; Pelletier G
Neuroendocrinology; 1998 Aug; 68(2):98-104. PubMed ID: 9705576
[TBL] [Abstract][Full Text] [Related]
19. The kappa-opioid receptor agonist MR-2034 stimulates the rat hypothalamic-pituitary-adrenal axis: studies in vivo and in vitro.
Calogero AE; Scaccianoce S; Burrello N; Nicolai R; Muscolo LA; Kling MA; Angelucci L; D'Agata R
J Neuroendocrinol; 1996 Aug; 8(8):579-85. PubMed ID: 8866244
[TBL] [Abstract][Full Text] [Related]
20. The role of CRF2 receptors in corticotropin-releasing factor- and urocortin-induced anorexia.
Smagin GN; Howell LA; Ryan DH; De Souza EB; Harris RB
Neuroreport; 1998 May; 9(7):1601-6. PubMed ID: 9631473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
